Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMBEV S.A. Regulatory Filings 2021

Dec 8, 2021

30093_ffr_2021-12-09_d1187ec8-7af4-4d85-9da4-fb8a9ebaf831.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

6-K 1 ambevsacvm358nov2021_6k.htm AMBEVSACVM358NOV2021_6K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of December, 2021

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor 04530-000 São Paulo, SP Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F X Form 40-F _

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _ No X_

Field: Page; Sequence: 1

Field: /Page

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In November 2021:

(X) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev Luxembourg S.À.R.L. CPF/CNPJ:
Qualification: Subsidiary (controlled)
Initial Balance
Securities / Derivatives Securities Characteristics (2) Quantity
Derivatives Swap referenced in Shares 0
Derivatives Swap referenced in ADR 0
Transactions in the month
Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3)
Final Balance
Securities / Derivatives Securities Characteristics (2) Quantity
Derivatives Swap referenced in Shares 0
Derivatives Swap referenced in ADR 0

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

(*) Each ADR is equivalent to 1 (one) share.

Field: Page; Sequence: 2

Field: /Page

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In November 2021:

( ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

(X) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A. CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury
Initial Balance
Securities / Derivatives Securities Characteristics (2) Quantity
Shares Common 4,380,900
ADR Common 0
Transactions in the month
Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3)
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 03 185,666 17.83 3,310,424.78
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 04 16,998 17.88 303,924.24
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 09 42,475 17.89 759,877.75
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 10 34,244 17.75 607,831.00
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 12 61,079 17.51 1,069,493.29
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 16 17,357 17.51 303,921.07
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 22 64,934 17.32 1,124,656.88
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 23 85,549 17.20 1,471,442.80
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 24 39,103 17.10 668,661.30
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 25 95,254 17.23 1,641,226.42
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 26 52,843 16.69 881,949.67
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 29 814,246 16.34 13,304,779.64
Shares Common Direct with the Company Buy - Plan of Shares Acquisition 30 302,433 16.06 4,857,073.98
Shares Common Direct with the Company Delivery of restricted Shares 09 16,013 17.70 283,430.10
Final Balance
Securities / Derivatives Securities Characteristics (2) Quantity
Shares Common 6,177,068
ADR Common 0

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

(*) Each ADR is equivalent to 1 (one) share.

Field: Page; Sequence: 3

Field: /Page

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: December 8, 2021

AMBEV S.A.
By: /s/ Lucas Machado Lira
Lucas Machado Lira Chief Financial and Investor Relations Officer